Aliases & Classifications for Bronchial Disease

MalaCards integrated aliases for Bronchial Disease:

Name: Bronchial Disease 12 14
Bronchial Diseases 51 41 69
Bronchial Disorders 40
Bronchial Spasm 69
Bronchospasm 12

Classifications:



External Ids:

Disease Ontology 12 DOID:1176
MeSH 41 D001982
SNOMED-CT 64 41427001

Summaries for Bronchial Disease

MedlinePlus : 40 When you breathe in, the air travels down through your trachea (windpipe). It then goes through two tubes to your lungs. These tubes are your bronchi. Bronchial disorders can make it hard for you to breathe. The most common problem with the bronchi is bronchitis, an inflammation of the tubes. It can be acute or chronic. Other problems include Bronchiectasis - a condition in which damage to the airways causes them to widen and become flabby and scarred Exercise-induced bronchospasm - a breathing problem that happens when your airways shrink while you are exercising Bronchiolitis - an inflammation of the small airways that branch off from the bronchi Bronchopulmonary dysplasia - a chronic lung condition in infants, most often premature infants

MalaCards based summary : Bronchial Disease, also known as bronchial diseases, is related to bronchitis and pulmonary tuberculosis, and has symptoms including expiratory wheeze, inspiratory wheeze and wheezing. An important gene associated with Bronchial Disease is ELANE (Elastase, Neutrophil Expressed), and among its related pathways/superpathways are Innate Immune System and ERK Signaling. The drugs Tobramycin and Amikacin have been mentioned in the context of this disorder. Affiliated tissues include lung, testes and t cells, and related phenotypes are hematopoietic system and immune system

Disease Ontology : 12 A lower respiratory tract disease that affects the airways leading into the lungs, which is caused due to inflammation of the bronchi and bronchioles, infection, or blockage.

Related Diseases for Bronchial Disease

Diseases related to Bronchial Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 181)
# Related Disease Score Top Affiliating Genes
1 bronchitis 32.2 CCL11 CXCL8 ELANE IL5 RNASE3 TNF
2 pulmonary tuberculosis 30.3 IL4 TLR9 TNF
3 asthma 30.2 ADAM33 ADRB2 AREG CCL11 CCL5 CXCL8
4 interstitial lung disease 30.0 CCL5 CXCL8 IL4 TNF
5 colitis 30.0 CXCL8 IL4 TLR9 TNF
6 lung disease 29.7 CCL5 CXCL8 ELANE IL13 IL5 TLR9
7 bronchiolitis 29.4 CCL11 CCL5 CXCL8 IL13 IL4 IL5
8 bronchiectasis 10.8
9 cytokine deficiency 10.7 IL13 IL5
10 paragonimiasis 10.7 IL13 IL5 RNASE3
11 apple allergy 10.7 IL13 IL4 IL5
12 atopic keratoconjunctivitis 10.7 IL4 IL5 RNASE3
13 intrinsic asthma 10.7 IL4 IL5 RNASE3
14 strongyloidiasis 10.7 CCL11 IL13 IL5
15 chronic tic disorder 10.7 IL13 IL4 IL5
16 blepharoconjunctivitis 10.7 CCL11 IL4 RNASE3
17 tropical endomyocardial fibrosis 10.7 IL4 TNF
18 angioimmunoblastic lymphadenopathy with dysproteinemia 10.7 IL13 IL5 TNF
19 eosinophilic gastroenteritis 10.7 CCL11 IL5 RNASE3
20 enterobiasis 10.7 IL13 IL4 IL5
21 milk allergy 10.7 IL4 IL5 RNASE3
22 scleritis 10.7 IL4 IL5 TNF
23 pustulosis palmaris et plantaris 10.6 ELANE IL5 TNF
24 penicillin allergy 10.6 IL13 IL4 STAT6
25 loeffler endocarditis 10.6 IL5 RNASE3
26 coccidiosis 10.6 IL4 TLR9 TNF
27 beta-lactam allergy 10.6 IL13 IL4 STAT6
28 lichen disease 10.6 IL4 TLR9 TNF
29 pemphigoid gestationis 10.6 CCL11 IL5
30 respiratory syncytial virus infectious disease 10.6 CCL5 IL13 IL5
31 cellulitis 10.6 IL5 RNASE3 TNF
32 primary amebic meningoencephalitis 10.6 IL4 IL5 STAT6
33 papillary conjunctivitis 10.6 CCL11 CXCL8 IL4
34 giant papillary conjunctivitis 10.6 CCL11 CXCL8 IL4
35 cardiac rupture 10.6 CXCL8 ELANE FLNC
36 cough variant asthma 10.6 IL4 IL5 RNASE3 TRPV1
37 extrinsic cardiomyopathy 10.6 IL4 TLR9 TNF
38 aspergillosis 10.6 ELANE IL4 IL5 TLR9
39 churg-strauss syndrome 10.6 IL5 RNASE3 TNF
40 scorpion envenomation 10.6 CCL5 TNF
41 keratoconjunctivitis sicca 10.6 IL4 TLR9 TNF
42 vernal conjunctivitis 10.6 IL4 MS4A2 RNASE3
43 wells syndrome 10.6 CXCL8 IL5 RNASE3
44 tungiasis 10.6 CXCL8 IL4 TNF
45 inflammatory bowel disease 4 10.6 IL13 IL4 IL5 RNASE3
46 genital herpes 10.6 CCL5 IL4 TLR9
47 angiostrongyliasis 10.6 CCL11 IL13 IL4 IL5
48 latex allergy 10.6 IL13 IL4 IL5 RNASE3
49 bronchopulmonary dysplasia 10.6 CXCL8 ELANE RNASE3
50 paracoccidioidomycosis 10.6 IL4 IL5 TNF

Graphical network of the top 20 diseases related to Bronchial Disease:



Diseases related to Bronchial Disease

Symptoms & Phenotypes for Bronchial Disease

UMLS symptoms related to Bronchial Disease:


expiratory wheeze, inspiratory wheeze, wheezing, snoring, dyspnea, coughing, apnea

MGI Mouse Phenotypes related to Bronchial Disease:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 10.21 ADRB2 IL33 AREG IL4 CCL11 CCL5
2 immune system MP:0005387 10.16 ADRB2 IL33 AREG IL4 CCL11 CCL5
3 homeostasis/metabolism MP:0005376 10.13 STAT6 IL13 ADRB2 IL33 AREG IL4
4 digestive/alimentary MP:0005381 10.01 IL13 IL33 AREG IL4 IL5 TLR9
5 integument MP:0010771 9.81 STAT6 IL13 IL33 AREG IL4 FLNC
6 no phenotypic analysis MP:0003012 9.5 ADAM33 IL13 ADRB2 IL33 IL4 TNF
7 respiratory system MP:0005388 9.32 STAT6 IL13 IL33 IL4 CCL11 CYSLTR1

Drugs & Therapeutics for Bronchial Disease

Drugs for Bronchial Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 652)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Tobramycin Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 32986-56-4 36294 5496
2
Amikacin Approved, Investigational, Vet_approved Phase 4,Phase 1,Phase 2 37517-28-5 37768
3
Bromhexine Approved Phase 4 3572-43-8
4
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 51-43-4 5816
5 Racepinephrine Approved Phase 4,Phase 3,Phase 2,Phase 1 329-65-7
6
Ipratropium Approved Phase 4,Phase 3,Phase 2,Phase 1 22254-24-6, 60205-81-4 43232
7
Magnesium Sulfate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 7487-88-9 24083
8
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 83-43-2 6741
9
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-24-8 5755
10
Benzocaine Approved, Investigational Phase 4,Phase 3,Phase 2 1994-09-7, 94-09-7 2337
11 Cisatracurium Approved, Experimental Phase 4 96946-41-7
12
Dexmedetomidine Approved, Vet_approved Phase 4 76631-46-4, 113775-47-6 5311068 56032 68602
13
Etomidate Approved Phase 4 33125-97-2 667484 36339
14
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Phase 2,Phase 3 437-38-7 3345
15
Midazolam Approved, Illicit Phase 4,Phase 1 59467-70-8 4192
16
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3 2078-54-8 4943
17
Remifentanil Approved Phase 4 132875-61-7 60815
18
Montelukast Approved Phase 4,Phase 2,Phase 3,Phase 1 158966-92-8 5281040
19
Bambuterol Approved, Investigational Phase 4 81732-65-2, 81732-46-9 54766
20
Terbutaline Approved Phase 4,Phase 3,Phase 2 23031-25-6 5403
21
Budesonide Approved Phase 4,Phase 2,Phase 3,Phase 1 51333-22-3 5281004 63006
22
Ephedrine Approved Phase 4,Phase 3,Phase 2 299-42-3 9294
23
Guaifenesin Approved, Investigational, Vet_approved Phase 4,Phase 3 93-14-1 3516
24
Pseudoephedrine Approved Phase 4,Phase 3,Phase 2 90-82-4 7028
25
Procaterol Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 72332-33-3 688561
26
Prednisone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 53-03-2 5865
27
Nitric Oxide Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 10102-43-9 145068
28
Dexlansoprazole Approved, Investigational Phase 4,Phase 3 138530-94-6, 103577-45-3 9578005
29
Lansoprazole Approved, Investigational Phase 4,Phase 3 103577-45-3 3883
30
Azithromycin Approved Phase 4,Phase 3,Phase 2,Phase 1 83905-01-5 53477736 447043 55185
31
Acetylcysteine Approved, Investigational Phase 4,Phase 2 616-91-1 12035
32
Levofloxacin Approved, Investigational Phase 4,Phase 3,Phase 2 100986-85-4 149096
33
Ofloxacin Approved Phase 4,Phase 3,Phase 2 82419-36-1 4583
34
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-02-2 5743
35
Omalizumab Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 242138-07-4
36
Menthol Approved Phase 4,Phase 3,Phase 2,Early Phase 1 2216-51-5 16666
37
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2 51-45-6, 75614-87-8 774
38
Ciclesonide Approved, Investigational Phase 4,Phase 3,Phase 2 126544-47-6, 141845-82-1 444033
39
Citalopram Approved Phase 4 59729-33-8 2771
40
Hydrocortisone Approved, Vet_approved Phase 4,Phase 2,Phase 1 50-23-7 657311 5754
41
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-78-2 2244
42
Theophylline Approved Phase 4,Phase 3,Phase 2 58-55-9 2153
43
Aztreonam Approved Phase 4,Phase 3,Phase 2 78110-38-0 5742832 5362041
44
Erythromycin Approved, Investigational, Vet_approved Phase 4 114-07-8 12560
45
Mechlorethamine Approved, Investigational Phase 4,Phase 3,Phase 2 51-75-2 4033
46
Telithromycin Approved Phase 4,Phase 3 191114-48-4 0 5462516
47
Varenicline Approved, Investigational Phase 4 249296-44-4 5310966
48
Cetirizine Approved Phase 4,Phase 3 83881-51-0 2678
49
Desloratadine Approved, Investigational Phase 4,Phase 3 100643-71-8 124087
50
Diphenhydramine Approved, Investigational Phase 4 58-73-1, 147-24-0 3100

Interventional clinical trials:

(show top 50) (show all 2927)

# Name Status NCT ID Phase Drugs
1 Vitamin D as an Adjunctive Treatment in Patients With Non-Cystic Fibrosis Bronchiectasis Unknown status NCT02507843 Phase 4 Cholecalciferol;Placebo
2 A Study to Access Safety and Efficacy of Nebulized Tobramycin in Patients With Bronchiectasis Unknown status NCT01677403 Phase 4 Tobramycin;Saline
3 Combined Administration of Nebulized Amikacin in Patients With Acute Exacerbation of Non-Cystic Fibrosis Bronchiectasis Unknown status NCT02081963 Phase 4 Amikacin;Normal saline
4 Sunovion Brovana Versus Serevent Inspiratory Capacity High Resolution Computed Tomography Unknown status NCT01361984 Phase 4 Nebulized arformoterol;Salmeterol
5 Effect of Vitamin D Supplementation in Young South African Children Hospitalized With Acute Lower Respiratory Infection Unknown status NCT02054182 Phase 4 Vitamin D
6 Home Oxygen Therapy in Bronchiolitis Unknown status NCT01216553 Phase 4
7 Bronchiolitis All-study, SE-Norway Unknown status NCT00817466 Phase 4 Racemic adrenaline;Isotonic saline
8 Effects of Exercise Training on Systemic Inflammation an Muscle Repair According to the Obstructive Chronic Pulmonary Disease (COPD) Phenotype Unknown status NCT01431625 Phase 4
9 Nebulized Magnesium Sulfate as an Adjunct to Standard Therapy in Asthma Exacerbation Unknown status NCT02584738 Phase 4 Nebulized Magnesium Sulfate;Nebulized isotonic saline;Nebulized Salbutamol;Ipratropium bromide;Methylprednisolone or Prednisolone
10 Extra-fine Formoterol/Beclomethasone in Asthmatic Crisis Unknown status NCT02345993 Phase 4 Extra fine Formoterol/Beclomethasone
11 Effect of Dexmedetomidine on Levels of Plasma Inflammatory Factor in Asthma Patients Undergoing General Anesthesia Unknown status NCT02289391 Phase 4 Anesthesia induction;Anesthesia maintenance;Assisted anesthesia
12 Comparison of Daily Mometasone Furoate Nasal Spray Alone Versus a Combination With Montelukast for Treatment of Chronic Rhinosinusitis With Asthma After Functional Endoscopic Sinus Surgery Unknown status NCT02110654 Phase 4 Montelukast;mometasone furoate nasal spray
13 Effect of Vitamin D Supplementation on the Control of Asthma in Children at a South African Academic Hospital Unknown status NCT02053402 Phase 4 Vitamin D
14 Efficacy of Bronchial Thermoplasty in Korean Unknown status NCT02031263 Phase 4
15 The Effect of Bronchodilator on Eosinophilic Bronchitis and Cough Variant Asthma Unknown status NCT02002754 Phase 4 Bambuterol Hydrochloride tablets
16 Therapeutic Effect of Different Treatment Course With Inhaled Corticosteroids in Eosinophilic Bronchitis Patients Unknown status NCT02002715 Phase 4 Inhaled budesonide
17 Efficacy and Safety of Activation Energy Serum (AES) Versus Placebo in Persistent Asthma. Unknown status NCT01939951 Phase 4
18 Optimization of Inhaled Corticosteroid Treatment in Adult Patients With Asthma Guided by Exhaled NO Measurement at Home Unknown status NCT01783132 Phase 4
19 Effects of Su-Huang Antitussive Capsule on Cough Variant Asthma Unknown status NCT01584804 Phase 4 Su-Huang antitussive capsule;Sugar pill
20 Assessing Decision Maker Tools for Asthma: the Asthma APGAR Unknown status NCT01446315 Phase 4
21 Effects of Leukotriene Modulator Montelukast on Cough Variant Asthma Unknown status NCT01404013 Phase 4 ICS/LABA;Montelukast;ICS/LABA and Montelukast
22 Efficacy and Safety Study of Procaterol Hydrochloride to Treat Patients With Cough Variant Asthma (CVA) Unknown status NCT01170429 Phase 4 Procaterol hydrochloride;Meptin placebo
23 Efficacy and Safety of add-on Montelukast to Inhaled Budesonide in the Treatment of Nonasthmatic Eosinophilic Bronchitis Unknown status NCT01121016 Phase 4 Montelukast
24 Assessment of Sublingual Immunotherapy in Children Allergic to House Dust Mites Unknown status NCT01052610 Phase 4 sublingual house dust mites allergen extract;placebo in sublingual applicator
25 Concentrations of Salmeterol in Blood and Urine Unknown status NCT00914901 Phase 4 inhaled salmeterol
26 Terbutaline Concentrations in Blood and Urine Unknown status NCT00914797 Phase 4 inhaled and oral terbutaline
27 Concentrations of Formoterol in Blood and Urine Unknown status NCT00914654 Phase 4 inhaled formoterol
28 Rapid Onset Action of Salbutamol Versus Formoterol Unknown status NCT00900874 Phase 4 salbutamol;Formoterol
29 Fluticasone/Salmeterol (FP/SM) Versus Double the Dose Fluticasone (FP) in Patients With Mild to Moderate Asthma Unknown status NCT00830505 Phase 4 fluticasone/ salmeterol;fluticasone
30 Vitamin D for the Treatment of Severe Asthma Unknown status NCT00712205 Phase 4 Placebo;Calcitriol
31 A Pilot Study Involving an Asthma Management Program for Inner-city Early Head Start Children Unknown status NCT00624429 Phase 4 Budesonide respules
32 Inflammatory, Functional and Image Composite Measure to Define Asthma Control Unknown status NCT00597064 Phase 4 prednisone
33 Assessment of Utility of Exhaled Nitric Oxide Measurement for Treatment Monitoring in Children With Asthma Unknown status NCT00500253 Phase 4
34 Evaluation of Efficacy of House Dust Mite Immunotherapy in Children With Bronchial Asthma Unknown status NCT00496574 Phase 4
35 Effect of Specific Immunotherapy to Dust Mites in Children With Asthma Unknown status NCT00496561 Phase 4
36 Treatment of Acute Asthma in ER With Combination of Systemic Steroids and Inhaled Steroids Unknown status NCT00397267 Phase 4 inhalation of corticosteroids
37 A Pilot Efficacy Study of Inhaled Albuterol Delivered With Akita Breath Control Unknown status NCT00385359 Phase 4 Albuterol
38 A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy. Unknown status NCT00237068 Phase 4 Lansoprazole; Solutab
39 Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 Mcg BID Unknown status NCT00235053 Phase 4 fluticasone/salmeterol DISKUS 250/50
40 Airway Clearance for Prevention of COPD Exacerbation Unknown status NCT00181207 Phase 4
41 Duration of Antibiotic Therapy in Community - Acquired Pneumonia Unknown status NCT01492387 Phase 4
42 Impact of Continuous Positive Airway Pressure on the Treatment of Acute Asthma Exacerbation Completed NCT01403467 Phase 4
43 Salmeterol-Fluticasone Combined Inhaled Therapy for Non-cystic Fibrosis Bronchiectasis Completed NCT02782312 Phase 4 ICS+LABA
44 Combivent vs. Salbutamol in Patients With Metacholine Induced Bronchospasm Completed NCT02182713 Phase 4 Salbutamol sulfate/Ipratropium bromide;Salbutamol
45 Efficacy of Azithromycin in Treatment of Bronchiectasis Completed NCT02107274 Phase 4 Azithromycin;Placebo for Azithromycin
46 Prevention of OM-85 on Bronchiectasis Exacerbation Completed NCT01968421 Phase 4 OM-85
47 The Role of Theophylline Plus Low-dose Formoterol-budesonide in Treatment of Bronchiectasis Completed NCT01769898 Phase 4 Formoterol-budesonide;Theophylline;Placebo
48 The Effect of Theophylline in the Treatment of Bronchiectasis Completed NCT01684683 Phase 4 Theophylline;Placebo(for Theophylline)
49 A Trial of Atorvastatin as an Anti-Inflammatory Agent in Non-Cystic Fibrosis Bronchiectasis Completed NCT01299181 Phase 4 Atorvastatin
50 Pulmonary Rehabilitation in Non Cystic Fibrosis Bronchiectasis Completed NCT00868075 Phase 4

Search NIH Clinical Center for Bronchial Disease

Inferred drug relations via UMLS 69 / NDF-RT 47 :


Cochrane evidence based reviews: bronchial diseases

Genetic Tests for Bronchial Disease

Anatomical Context for Bronchial Disease

MalaCards organs/tissues related to Bronchial Disease:

38
Lung, Testes, T Cells, Bone, Heart, Neutrophil, Trachea

Publications for Bronchial Disease

Articles related to Bronchial Disease:

(show all 46)
# Title Authors Year
1
Novel Mutation of Interferon-I^ Receptor 1 Gene Presenting as Early Life Mycobacterial Bronchial Disease. ( 27868075 )
2016
2
A case of IgG4-related bronchial disease successfully treated with inhaled corticosteroids. ( 26441152 )
2015
3
Progression and prognostic indicators of bronchial disease in children with sickle cell disease. ( 24699774 )
2014
4
Lower respiratory tract endoscopy in the cat: diagnostic approach to bronchial disease. ( 24152702 )
2013
5
Inhaled budesonide therapy in cats with naturally occurring chronic bronchial disease (feline asthma and chronic bronchitis). ( 24000786 )
2013
6
Correlation of bronchoalveolar eosinophilic percentage with airway responsiveness in cats with chronic bronchial disease. ( 23617298 )
2013
7
'Heavier the interval than the consummation': bronchial disease in Sean O Riordain's diaries. ( 24002457 )
2013
8
Use of propentofylline in feline bronchial disease: prospective, randomized, positive-controlled study. ( 20810552 )
2010
9
Radiographic abnormalities in cats with feline bronchial disease and intra- and interobserver variability in radiographic interpretation: 40 cases (1999-2006). ( 19210258 )
2009
10
Tobacco as an allergen in bronchial disease. ( 17458428 )
2007
11
The nose: gatekeeper and trigger of bronchial disease. ( 17020064 )
2006
12
Twenty-five cases of feline bronchial disease (1995-2000). ( 15135355 )
2004
13
Flexible bronchoscopy: a safe method for metal stent implantation in bronchial disease. ( 10735670 )
2000
14
The role of airway stents in the management of pediatric tracheal, carinal, and bronchial disease. ( 11053808 )
2000
15
Elastic deformation properties of implanted endobronchial wire stents in benign and malignant bronchial disease: A radiographic in vivo evaluation. ( 10094988 )
1999
16
Pneumocystis carinii infection in patients with chronic bronchial disease. ( 8598795 )
1996
17
Atypical bronchoplasty to lung cancer and benign bronchial disease. ( 8073432 )
1994
18
From alveoli back to bronchi. Contribution of bronchoalveolar (BAL) and bronchial (BL) lavage to the understanding of bronchial disease. International workshop. Verno, Italy, April 19-21, 1990. ( 1349762 )
1992
19
Broncholithiasis: a neglected bronchial disease in this country. Illustration of three cases. ( 1581838 )
1992
20
Clinical, radiographic, and bronchial cytologic features of cats with bronchial disease: 65 cases (1980-1986). ( 2470710 )
1989
21
Cefetamet pivoxil (Ro 15-8075) and amoxicillin in the treatment of bacterial exacerbations of chronic bronchial disease--preliminary results. ( 16312635 )
1989
22
Aspiration of solid food particles into lungs of patients with gastroesophageal reflux and chronic bronchial disease. ( 3338306 )
1988
23
Comparison of CT and fiberoptic bronchoscopy in the evaluation of bronchial disease. ( 3491497 )
1987
24
Beta-blockers and the patient with bronchial disease. ( 2879812 )
1986
25
Chronic bronchial disease of the cat. ( 3907110 )
1985
26
End-inspiratory flow reduction in the forced flow-volume curve as a sign of unilateral bronchial disease. ( 4080042 )
1985
27
Bronchial disease in ulcerative colitis. ( 7444824 )
1980
28
Quantitative sputum gram stains in chronic bronchial disease. ( 43418 )
1979
29
Manual and computer methods for measuring lung mechanics in children with bronchial disease. ( 752398 )
1978
30
Anaerobic bacteriology of chronic bronchial disease. With a refined method of sampling bronchial secretions. ( 588430 )
1977
31
Physical properties of sputum and respiratory function in chronic bronchial disease. ( 4778954 )
1973
32
Relationship of physical sputum characteristics and ventilatory capacity in chronic bronchial disease. ( 4695750 )
1973
33
Sputum cell dynamics in bacterial exacerbations of chronic bronchial disease. ( 5019450 )
1972
34
Anhidrotic ectodermal dysplasia: predisposition to bronchial disease. ( 5539281 )
1971
35
A BREATHING EXERCISE PROGRAM FOR CHRONIC BRONCHIAL DISEASE AND PULMONARY EMPHYSEMA. ( 14348275 )
1965
36
NATURAL HISTORY OF PLACEBO-TREATED PATIENTS WITH CHRONIC BRONCHIAL DISEASE OBSERVED FOR 7 YEARS. ( 14288021 )
1964
37
SUPPRESSIVE THERAPY WITH ANTIBIOTICS IN PATIENTS WITH CHRONIC BRONCHIAL DISEASE AND HYPOGAMMAGLOBULINEMIA. ( 14274991 )
1963
38
EXPECTORANTS IN THE MANAGEMENT OF CHRONIC OBSTRUCTIVE BRONCHIAL DISEASE. ( 14084008 )
1963
39
Sweat chloride in patients with chronic bronchial disease and its relation to mucoviscidosis (cystic fibrosis). ( 14021816 )
1963
40
The disordered physiology of obstructive bronchial disease. ( 13844453 )
1960
41
Bronchial disease and bronchography in pulmonary tuberculosis. ( 13560785 )
1958
42
Laboratory differentiation of chronic bronchial disease; an investigation of 117 cases. ( 13503231 )
1958
43
A correlated bronchographic and histopathologic study of bronchial disease in 216 tuberculous patients. ( 13313954 )
1956
44
Allergic bronchial disease. ( 13164601 )
1954
45
Bronchial disease in lungs resected for pulmonary tuberculosis. ( 13104881 )
1953
46
Bronchial disease in lungs resected for pulmonary tuberculosis. ( 13136317 )
1953

Variations for Bronchial Disease

Expression for Bronchial Disease

Search GEO for disease gene expression data for Bronchial Disease.

Pathways for Bronchial Disease

Pathways related to Bronchial Disease according to GeneCards Suite gene sharing:

(show all 35)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
14.04 CCL11 CCL5 CXCL8 ELANE IL13 IL33
2
Show member pathways
13.81 AREG CCL11 CCL5 CXCL8 FLNC IL13
3
Show member pathways
13.52 AREG CCL11 CCL5 CXCL8 IL13 IL4
4
Show member pathways
13.36 CCL11 CCL5 CXCL8 IL13 IL33 IL4
5
Show member pathways
13.36 AREG CCL11 CCL5 CXCL8 IL13 IL4
6
Show member pathways
13.28 AREG CCL11 CCL5 CXCL8 FLNC IL13
7 12.78 CXCL8 IL13 IL4 IL5 STAT6
8
Show member pathways
12.78 CCL11 CXCL8 IL13 IL4 IL5 MS4A2
9
Show member pathways
12.77 CCL5 CXCL8 IL13 IL33 IL4 TLR9
10
Show member pathways
12.59 IL13 IL4 IL5 STAT6 TNF
11
Show member pathways
12.58 IL13 IL4 IL5 MS4A2 TNF
12 12.55 CCL5 IL4 STAT6 TLR9 TNF
13
Show member pathways
12.37 IL13 IL4 IL5 STAT6 TSLP
14
Show member pathways
12.3 CCL11 CXCL8 IL13 IL4 IL5 TNF
15
Show member pathways
12.18 CCL11 CXCL8 IL4 TLR9 TNF
16
Show member pathways
12.13 CXCL8 IL13 IL4 IL5 TNF
17 11.9 CCL11 CXCL8 IL13 IL4 STAT6 TNF
18 11.83 IL4 IL5 TNF
19 11.83 CXCL8 IL13 IL4 IL5
20 11.79 CCL5 CXCL8 TNF
21
Show member pathways
11.79 CXCL8 IL4 IL5 TNF
22 11.7 IL4 IL5 TLR9 TNF
23 11.68 CCL11 IL4 IL5 STAT6
24 11.64 IL13 IL33 IL4 IL5 TNF TSLP
25 11.52 CXCL8 TLR9 TNF
26 11.5 CCL11 CCL5 CXCL8 IL13 IL4 IL5
27 11.49 CCL5 CXCL8 IL13 IL4 TNF
28 11.26 IL13 IL4 IL5 TNF
29 11.21 IL13 IL4 IL5
30 11.17 CCL5 CXCL8 TNF
31 11.16 AREG CCL11 IL13 IL33 IL4 IL5
32 11.1 CCL11 CCL5 CXCL8 IL13 IL4 IL5
33 10.96 AREG CCL11 CCL5 CXCL8 IL13 IL4
34 10.8 IL13 IL4 IL5
35 10.67 AREG IL13 IL33 IL4 IL5 TNF

GO Terms for Bronchial Disease

Cellular components related to Bronchial Disease according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.73 CCL11 CCL5 CXCL8 ELANE IL13 IL33
2 external side of plasma membrane GO:0009897 9.46 IL13 MS4A2 TNF TRPV1
3 extracellular space GO:0005615 9.44 AREG CCL11 CCL5 CXCL8 ELANE IL13

Biological processes related to Bronchial Disease according to GeneCards Suite gene sharing:

(show all 33)
# Name GO ID Score Top Affiliating Genes
1 cell surface receptor signaling pathway GO:0007166 9.95 ADRB2 CYSLTR1 MS4A2 TRPV1
2 defense response to bacterium GO:0042742 9.91 ELANE RNASE3 TLR9 TNF
3 cellular calcium ion homeostasis GO:0006874 9.83 CCL11 CCL5 ELANE
4 chemotaxis GO:0006935 9.83 CCL11 CCL5 CXCL8 CYSLTR1 IL4
5 cellular response to tumor necrosis factor GO:0071356 9.81 CCL11 CCL5 CXCL8 TRPV1
6 cellular response to interleukin-1 GO:0071347 9.79 CCL11 CCL5 CXCL8
7 chemokine-mediated signaling pathway GO:0070098 9.79 CCL11 CCL5 CXCL8
8 positive regulation of inflammatory response GO:0050729 9.76 IL33 TLR9 TSLP
9 immune response GO:0006955 9.76 CCL11 CCL5 CXCL8 IL13 IL4 IL5
10 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.75 CCL5 IL13 TSLP
11 neutrophil chemotaxis GO:0030593 9.74 CCL11 CCL5 CXCL8
12 positive regulation of smooth muscle cell proliferation GO:0048661 9.71 CCL5 ELANE IL13 TNF
13 positive regulation of interleukin-6 production GO:0032755 9.67 IL33 TLR9 TNF TSLP
14 microglial cell activation GO:0001774 9.66 IL13 TRPV1
15 negative regulation of growth of symbiont in host GO:0044130 9.65 ELANE TNF
16 response to molecule of bacterial origin GO:0002237 9.64 CXCL8 TLR9
17 positive regulation of podosome assembly GO:0071803 9.64 IL5 TNF
18 positive regulation of immunoglobulin secretion GO:0051024 9.63 IL33 IL5
19 negative regulation of G-protein coupled receptor protein signaling pathway GO:0045744 9.63 CCL5 CXCL8
20 positive regulation of chemokine production GO:0032722 9.63 TLR9 TNF TSLP
21 neutrophil activation GO:0042119 9.62 CCL5 CXCL8
22 inflammatory response GO:0006954 9.61 CCL11 CCL5 CXCL8 IL13 IL5 MS4A2
23 diet induced thermogenesis GO:0002024 9.6 ADRB2 TRPV1
24 eosinophil chemotaxis GO:0048245 9.59 CCL11 CCL5
25 positive regulation of interleukin-8 biosynthetic process GO:0045416 9.56 ELANE TNF
26 positive regulation of B cell proliferation GO:0030890 9.56 IL13 IL4 IL5 TLR9
27 positive regulation of immunoglobulin production GO:0002639 9.55 IL13 TLR9
28 positive regulation of interleukin-5 production GO:0032754 9.54 IL33 TSLP
29 type 2 immune response GO:0042092 9.52 IL33 IL4
30 positive regulation of interleukin-13 production GO:0032736 9.5 IL33 IL4 TSLP
31 positive regulation of isotype switching to IgE isotypes GO:0048295 9.49 IL4 STAT6
32 negative regulation of complement-dependent cytotoxicity GO:1903660 9.48 IL13 IL4
33 regulation of receptor activity GO:0010469 9.32 AREG CCL11 CCL5 CXCL8 IL13 IL33

Molecular functions related to Bronchial Disease according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 9.32 AREG CCL11 CCL5 CXCL8 IL13 IL33
2 chemokine activity GO:0008009 9.13 CCL11 CCL5 CXCL8

Sources for Bronchial Disease

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34